# Technical Optimization of Detection of KRAS, BRAF and NRAS Mutations on Tumor DNA Circulating in Metastatic Colorectal Cancer

> **NCT02827565** · NA · COMPLETED · sponsor: **Institut de Cancérologie de Lorraine** · enrollment: 30 (actual)

## Conditions studied

- Metastatic Colorectal Cancer

## Interventions

- **OTHER:** KRAS, NRAS et BRAF mutation analysis from circulating plasma DNA

## Key facts

- **NCT ID:** NCT02827565
- **Lead sponsor:** Institut de Cancérologie de Lorraine
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-03
- **Primary completion:** 2017-01-05
- **Final completion:** 2017-01-19
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-08-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02827565

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02827565, "Technical Optimization of Detection of KRAS, BRAF and NRAS Mutations on Tumor DNA Circulating in Metastatic Colorectal Cancer". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02827565. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*